Suppr超能文献

肝脏巨大血管瘤:剜除术比切除术更好吗?

Giant haemangioma of the liver: is enucleation better than resection?

作者信息

Singh Rajneesh Kumar, Kapoor Sorabh, Sahni Peush, Chattopadhyay Tushar K

机构信息

Department of Gastrointestinal Surgery and Liver Transplantation, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Ann R Coll Surg Engl. 2007 Jul;89(5):490-3. doi: 10.1308/003588407X202038.

Abstract

INTRODUCTION

Haemangioma is the most common liver tumour. Treatment is indicated for symptomatic tumours, rapid increase in size, rupture or doubt in diagnosis. There is continuing debate regarding the ideal method of surgical treatment for liver haemangiomas, with some surgeons favouring enucleation over liver resection.

PATIENTS AND METHODS

Retrospective analysis of prospectively compiled database of patients who were surgically treated for liver haemangioma.

RESULTS

Between 1987 and 2003, we operated on 21 patients with liver haemangioma. Pre-operative diagnosis on imaging was made in 16 patients (13 symptomatic, 3 had progressive increase in size). In five patients, the indication of surgery was uncertain diagnosis. Enucleation was performed in 9 patients and liver resection in 12. The size of the haemangioma was similar in the enucleation and resection groups (8.9 cm versus 10 cm; P = 0.85). The mean intra-operatiive blood loss was significantly less in the enucleation group (400 ml versus 1330 ml; P = 0.004). The mean operative time was significantly less in the enucleation group as compared to the resection group (170 min versus 230 min; P = 0.035). Five patients had major postoperative morbidity in the resection group as compared to none in the enucleation group (P = 0.045). The duration of hospital stay was significantly longer in the resection group.(9.9 days versus 5.6 days; P = 0.005).

CONCLUSIONS

Enucleation of liver haemangiomas is safer, quicker and associated with less morbidity than liver resection. Except for some situations, such as uncertain diagnosis or total replacement of a lobe, we recommend enucleation as the surgical procedures of choice for the treatment of hepatic haemangiomas.

摘要

引言

肝血管瘤是最常见的肝脏肿瘤。有症状的肿瘤、体积迅速增大、破裂或诊断存疑时需进行治疗。关于肝血管瘤手术治疗的理想方法一直存在争议,一些外科医生更倾向于采用摘除术而非肝切除术。

患者与方法

对前瞻性收集的接受肝血管瘤手术治疗患者的数据库进行回顾性分析。

结果

1987年至2003年间,我们为21例肝血管瘤患者实施了手术。16例患者(13例有症状,3例体积逐渐增大)术前通过影像学做出诊断。5例患者手术指征为诊断不确定。9例行摘除术,12例行肝切除术。摘除术组和切除术组的血管瘤大小相似(8.9厘米对10厘米;P = 0.85)。摘除术组术中平均失血量显著少于切除术组(400毫升对1330毫升;P = 0.004)。与切除术组相比,摘除术组平均手术时间显著更短(170分钟对230分钟;P = 0.035)。切除术组有5例患者术后出现严重并发症,而摘除术组无(P = 0.045)。切除术组住院时间显著更长(9.9天对5.6天;P = 0.005)。

结论

肝血管瘤摘除术比肝切除术更安全、更快,且并发症更少。除了某些情况,如诊断不确定或一个肝叶完全被替代,我们推荐摘除术作为治疗肝血管瘤的首选手术方式。

相似文献

1
Giant haemangioma of the liver: is enucleation better than resection?
Ann R Coll Surg Engl. 2007 Jul;89(5):490-3. doi: 10.1308/003588407X202038.
3
[Surgical treatment of liver haemangiomas in a third level hospital in south-east Mexico].
Cir Cir. 2016 Nov-Dec;84(6):477-481. doi: 10.1016/j.circir.2016.03.009. Epub 2016 Apr 27.
4
[Personal experience in embolization of liver hemangiomas].
Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):349-54.
6
7
Surgical approach to symptomatic giant cavernous hemangioma of the liver.
Hepatogastroenterology. 2005 Jan-Feb;52(61):183-6.
8
Giant cavernous liver hemangiomas: effect of operative approach on outcome.
Arch Surg. 2004 Aug;139(8):818-21; discussion 821-3. doi: 10.1001/archsurg.139.8.818.
9
Enucleation versus hepatectomy for giant hepatic haemangiomas: a meta-analysis.
Ann R Coll Surg Engl. 2017 Mar;99(3):237-241. doi: 10.1308/rcsann.2016.0349. Epub 2016 Nov 21.
10
Surgical treatment of cavernous haemangiomas of the liver.
Langenbecks Arch Chir. 1993;378(6):322-4. doi: 10.1007/BF01876432.

引用本文的文献

1
Surgery for a symptomatic massive liver haemangioma.
BMJ Case Rep. 2024 Mar 19;17(3):e257370. doi: 10.1136/bcr-2023-257370.
2
Surgery for symptomatic hepatic hemangioma: Resection vs. enucleation, an experience over two decades.
Ann Hepatobiliary Pancreat Surg. 2023 Aug 31;27(3):258-263. doi: 10.14701/ahbps.22-130. Epub 2023 May 2.
4
Enucleation versus hepatectomy for hepatic hemangiomas: A meta-analysis.
Front Surg. 2022 Jul 28;9:960768. doi: 10.3389/fsurg.2022.960768. eCollection 2022.
5
The surgical outcomes and risk factors of giant hepatic haemangiomas: a single centre experience.
BMC Surg. 2022 Jul 17;22(1):278. doi: 10.1186/s12893-022-01721-w.
6
A Comprehensive Review of Hepatic Hemangioma Management.
J Gastrointest Surg. 2022 Sep;26(9):1998-2007. doi: 10.1007/s11605-022-05382-1. Epub 2022 Jun 15.
7
Surgical management of giant hepatic hemangioma: A 10-year single center experience.
Ann Med Surg (Lond). 2021 Jul 6;69:102542. doi: 10.1016/j.amsu.2021.102542. eCollection 2021 Sep.
8
Revisiting the Surgical Management of Giant Hepatic Hemangiomas: Enucleation Versus Anatomical Resection?
J Clin Exp Hepatol. 2021 May-Jun;11(3):321-326. doi: 10.1016/j.jceh.2020.09.008. Epub 2020 Oct 2.
9
Outcomes of surgery for giant hepatic hemangioma.
BMC Surg. 2021 Apr 8;21(1):186. doi: 10.1186/s12893-021-01185-4.

本文引用的文献

1
Giant liver hemangioma: therapy by enucleation or liver resection.
World J Surg. 2005 Jul;29(7):890-3. doi: 10.1007/s00268-005-7661-z.
2
Giant cavernous liver hemangiomas: effect of operative approach on outcome.
Arch Surg. 2004 Aug;139(8):818-21; discussion 821-3. doi: 10.1001/archsurg.139.8.818.
3
Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma.
J Am Coll Surg. 2003 Sep;197(3):392-402. doi: 10.1016/S1072-7515(03)00420-4.
4
Clinical experience of hepatic hemangioma undergoing hepatic resection.
Dig Dis Sci. 2003 May;48(5):916-20. doi: 10.1023/a:1023099529229.
5
Surgical management of benign tumors of the liver.
Int J Gastrointest Cancer. 2001;30(3):141-6. doi: 10.1385/IJGC:30:3:141.
6
Arterial embolization of giant hepatic hemangiomas.
Cardiovasc Intervent Radiol. 2003 Jan-Feb;26(1):92-6. doi: 10.1007/s00270-002-2648-8. Epub 2003 Jan 15.
7
Size of lesion is not a criterion for resection during management of giant liver haemangioma.
Br J Surg. 2002 Oct;89(10):1240-4. doi: 10.1046/j.1365-2168.2002.02219.x.
8
Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal.
Arch Surg. 2001 Sep;136(9):1033-8. doi: 10.1001/archsurg.136.9.1033.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验